(S (NP (NP (ADJP (RB Molecularly) (VBN targeted)) (NN contrast) (VBN enhanced) (NN ultrasound)) (-LRB- -LRB-) (NP (NN mCEUS)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB clinically) (JJ promising)) (NN approach)) (PP (IN for) (NP (NP (JJ early) (NN cancer) (NN detection)) (PP (IN through) (NP (NP (VBN targeted) (NN imaging)) (PP (IN of) (NP (NML (NN VEGFR2) (-LRB- -LRB-) (NN KDR) (-RRB- -RRB-)) (NNS receptors))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NML (JJ computational) (NN enhancement)) (NNS techniques)) (PP (IN for) (NP (NP (NN mCEUS)) (VP (VBN tailored) (S (VP (TO to) (VP (VB address) (NP (NP (DT the) (JJ unique) (NNS challenges)) (PP (IN of) (NP (NN imaging) (NN contrast) (NN accumulation)))) (PP (IN in) (NP (NNS humans))))))))))) (. .))
(S (NP (DT These) (NNS techniques)) (VP (VBP utilize) (NP (JJ dynamic) (NN analysis)) (S (VP (TO to) (VP (VB distinguish) (NP (ADJP (RB molecularly) (VBN bound)) (NN contrast) (NN agent)) (PP (IN from) (NP (NP (NP (JJ other) (NN contrast) (HYPH -) (NN mode)) (NP (NN signal) (NNS sources))) (, ,) (VP (VBG enabling) (NP (NP (NN analysis)) (PP (IN of) (NP (NN contrast) (NN agent) (NN accumulation)))) (S (VP (TO to) (VP (VB be) (VP (VBN performed) (PP (IN during) (NP (NN contrast) (NN bolus) (NN arrival))))))))))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN signal)) (PP (IN due) (PP (IN to) (NP (JJ molecular) (NN binding))))) (VP (VBZ is) (ADJP (JJS strongest)))))) (. .))
(S (NP (NP (NNP Applied)) (PP (IN to) (NP (NP (DT the) (CD 18) (JJ human) (NN patient) (NNS examinations)) (PP (IN of) (NP (NP (DT the) (NML (NML (JJ first)) (HYPH -) (PP (IN in) (HYPH -) (NP (JJ human) (JJ molecular) (NN ultrasound) (NN breast)))) (NN lesion) (NN study)) (, ,) (NP (JJ computational) (NN enhancement))))))) (VP (VBD improved) (NP (DT the) (NN ability)) (S (VP (TO to) (VP (VB differentiate) (PP (IN between) (NP (NP (NP (NN pathology)) (HYPH -) (VP (VBN proven) (NP (ADJP (NP (NN lesion) (CC and) (NN pathology)) (HYPH -) (VBN proven)) (JJ normal) (NN tissue)) (PP (IN in) (NP (NP (NML (JJ real) (HYPH -) (NN world)) (JJ human) (NN examination) (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBD involved) (NP (NP (DT both) (NN patient)) (CC and) (NP (NN probe) (NN motion))) (, ,) (PP (IN with) (NP (NP (NNS improvements)) (PP (IN in) (NP (NP (NN contrast) (NN ratio)) (PP (IN between) (NP (NN lesion)))))))))))))) (CC and) (NP (NP (JJ normal) (NN tissue)) (SBAR (WHNP (WDT that)) (S (PP (IN in) (NP (JJS most) (NNS cases))) (VP (VBP exceed) (NP (NP (DT an) (NN order)) (PP (IN of) (NP (NN magnitude)))) (PRN (-LRB- -LRB-) (NP (NN 10x)) (-RRB- -RRB-)))))))))))) (. .))
(S (ADVP (RB Notably)) (, ,) (NP (JJ computational) (NN enhancement)) (VP (VBD eliminated) (NP (NP (DT a) (JJ false) (JJ positive) (NN result)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN tissue) (NN leakage) (NN signal)) (VP (VBD was) (VP (VBN misinterpreted) (PP (IN by) (NP (NNS radiologists))) (S (VP (TO to) (VP (VB be) (NP (NN contrast) (NN agent) (NN accumulation))))))))))) (. .))
